Jianmin Jiang

This paper develops Apt-circRNAs for targeted antigen-presenting cell immunotherapy, showing efficacy in tumors and clinical trials.

This study benchmarks TELL-Seq for bacterial genome assembly, showing it can generate high-quality near-complete assemblies at lower cost and DNA input compared to PacBio HiFi.

The paper predicts potential B/T-cell epitopes for multiple coronaviruses and stores the results in a database for vaccine development.